ISPC iSpecimen Inc.
Price Chart
Executive Summary
iSpecimen priced a ~$2.5M private placement, issuing 488,281 shares at $5.12/share with pre-funded warrants, for working capital and marketing. The offering is capped at 19.99% of outstanding shares pending stockholder approval, and the company must file a proxy statement within 30 days of closing. This dilutive capital raise signals ongoing cash needs for a micro-cap with a $4M market cap.
Key Financial Metrics
Actionable Insight
The offering provides near-term cash but at significant dilution for a $4M market cap company. Monitor the proxy filing timeline and stockholder vote outcome; failure to obtain approval could trigger price-protection provisions. The stock may face continued pressure given the capital raise and going-concern risks highlighted in forward-looking statements.
Key Facts
- Private placement priced at $5.12/share for ~$2.5M gross proceeds.
- 488,281 shares issued; pre-funded warrants available to avoid >4.99% ownership.
- Offering capped at 19.99% of outstanding shares pending stockholder approval.
- Proceeds used for working capital, including up to $900K in marketing expenses.
- Expected closing on or about May 11, 2026.
- Company must file preliminary proxy within 30 days and hold stockholder meeting within 90 days post-closing.
- E.F. Hutton & Co. acting as exclusive placement agent.
Financial Impact
~$2.5M gross proceeds, representing ~12.2% dilution based on 488,281 shares vs. ~4M market cap (assuming ~4M shares outstanding pre-offering).
Risk Factors
- Substantial dilution to existing shareholders from the offering and potential anti-dilution adjustments.
- Risk of delisting if Nasdaq continued listing standards are not maintained.
- Going-concern uncertainty; company may need additional capital beyond this offering.
- Stockholder approval required for full share issuance; failure could limit future capital access.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3291413 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 1, 2026
8d ago
|
8-K
| $3.07 $3.00 | ▲ +2.28% | ▲ +1.56% | $2.92 (+4.89%) |
|
May 18, 2026
22d ago
|
DEFA14A
| $3.93 $3.67 | ▲ +6.62% | ▲ +5.97% | $2.92 (+25.70%) |
|
May 9, 2026
4w ago
|
Press Release
| $5.05 $4.54 | ▲ +10.10% | ▲ +9.96% | $2.92 (+42.18%) |
|
May 1, 2026
5w ago
|
8-K
| $5.40 $5.40 | · 0.00% | ▼ −0.80% | $2.92 (−45.93%) |
|
Apr 13, 2026
8w ago
|
8-K
| $4.36 $4.47 | ▼ −2.57% | ▼ −1.79% | $2.92 (+33.03%) |
|
Apr 10, 2026
8w ago
|
8-K
| $4.64 $4.36 | ▼ −6.03% | ▼ −7.24% | $2.92 (−37.07%) |
|
Mar 3, 2026
14w ago
|
DEFA14A
| $10.20 $9.88 | ▼ −3.14% | ▼ −2.56% | $2.92 (−71.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access